SRX failed Overall Progression free survival which measures progression of existing tumours and/or the development of new tumours in any organ or body site . Oncosil showing stable disease which is progression free survival.
Impact of Sirflox failure to meet primary end point, page-16
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.79M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.8¢ | 0.8¢ | $146.9K | 18.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 40 | 20491639 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 7540000 | 5 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| OSL (ASX) Chart |